{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T21:44:14Z","timestamp":1790545454521,"version":"4.1.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nuclear Medicine and Biology"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1016\/j.nucmedbio.2011.08.003","type":"journal-article","created":{"date-parts":[[2011,10,28]],"date-time":"2011-10-28T08:22:39Z","timestamp":1319790159000},"page":"227-233","source":"Crossref","is-referenced-by-count":10,"title":["Difficulties in dopamine transporter radioligand PET analysis: the example of LBT-999 using [18F] and [11C] labelling"],"prefix":"10.1016","volume":"39","author":[{"given":"Wadad","family":"Saba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Anne","family":"Peyronneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Doll\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Goutal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Bottlaender","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9ric","family":"Valette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nucmedbio.2011.08.003_bb0005","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.expneurol.2003.08.008","article-title":"Assessment of neuroimaging techniques as biomarkers of the progression of Parkinson's disease","volume":"184","author":"Brooks","year":"2003","journal-title":"Exp Neurol"},{"key":"10.1016\/j.nucmedbio.2011.08.003_bb0010","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s00259-005-0032-z","article-title":"Long-term assessment of striatal dopamine transporters in Parkinsonian patients with intrastriatal embryonic mesencephalic grafts","volume":"33","author":"Pogarell","year":"2006","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.nucmedbio.2011.08.003_bb0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0969-8051(99)00080-3","article-title":"18F-Labeled FECNT: a selective radioligand for PET imaging of brain dopamine transporters","volume":"27","author":"Goodman","year":"2000","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2011.08.003_bb0020","first-page":"855","article-title":"Initial human PET imaging studies with the dopamine transporter ligand 18F-FECNT","volume":"44","author":"Davis","year":"2003","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2011.08.003_bb0025","first-page":"520","article-title":"PET imaging of the dopamine transporter with 18F-FECNT: a polar radiometabolite confounds brain radioligand measurements","volume":"47","author":"Zoghbi","year":"2006","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2011.08.003_bb0030","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/S0022-3565(24)35151-1","article-title":"Pharmacological characterization of (E)-N-(3-iodoprop-2-enyl)-2\u03b2-carbomethoxy-3\u03b2-(4\u2032-methylphenyl)nortropane as a selective and potent inhibitor of the neuronal dopamine transporter","volume":"291","author":"Chalon","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.nucmedbio.2011.08.003_bb0035","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s00259-006-0277-1","article-title":"Identification and regional distribution in rat brain of radiometabolites of the dopamine transporter PET radioligand [11C]PE2I","volume":"34","author":"Shetty","year":"2007","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.nucmedbio.2011.08.003_bb0040","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1124\/jpet.105.096792","article-title":"Pharmacological characterization of (E)-N-(4-fluorobut-2-enyl)-2beta-carbomethoxy-3beta-(4\u2032tolyl)nortropane (LBT-999) as a highly promising fluorinated ligand for the dopamine transporter","volume":"317","author":"Chalon","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.nucmedbio.2011.08.003_bb0045","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s00259-005-0027-9","article-title":"Quantitative analyses of regional [11C]PE2I binding to the dopamine transporter in the human brain: a PET study","volume":"33","author":"Jucaite","year":"2006","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.nucmedbio.2011.08.003_bb0050","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/syn.20337","article-title":"[11C]LBT-999: a suitable radioligand for investigation of extra-striatal dopamine transporter with PET","volume":"61","author":"Saba","year":"2007","journal-title":"Synapse"},{"key":"10.1016\/j.nucmedbio.2011.08.003_bb0055","first-page":"S180","article-title":"Radiosynthesis of [F-18]LBT-999, a selective radioligand for the visualisation of the dopamine transporter with PET","volume":"48","author":"Doll\u00e9","year":"2005","journal-title":"J Label Compd Radiopharm"},{"key":"10.1016\/j.nucmedbio.2011.08.003_bb0060","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/jlcr.1412","article-title":"One-step radiosynthesis of [18F]LBT-999, a selective radioligand for the visualisation of the dopamine transporter with PET","volume":"50","author":"Doll\u00e9","year":"2007","journal-title":"J Label Compds Radiopharm"},{"key":"10.1016\/j.nucmedbio.2011.08.003_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.nucmedbio.2011.09.006","article-title":"In vitro and in vivo metabolism of [18F]LBT-999, a ligand for PET examination of the dopamine transporter. Part II: metabolism studies.","author":"Peyronneau","year":"2011","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2011.08.003_bb0070","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1021\/jm040185a","article-title":"Synthesis and monoamine transporter binding properties of 3beta-(3\u2032,4\u2032-disubstituted phenyl)tropane-2beta-carboxylic acid methyl esters","volume":"48","author":"Carroll","year":"2005","journal-title":"J Med Chem"},{"key":"10.1016\/j.nucmedbio.2011.08.003_bb0075","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1006\/nimg.1998.0366","article-title":"Visualization of the dopamine transporter in the human brain postmortem with the new selective ligand [125I]PE2I","volume":"9","author":"Hall","year":"1999","journal-title":"NeuroImage"},{"key":"10.1016\/j.nucmedbio.2011.08.003_bb0080","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/jcbfm.1990.127","article-title":"Graphical analysis of reversible radioligand binding time-activity measurements applied to [N-11C-methyl]-(\u2212)-cocaine PET studies in human subjects","volume":"10","author":"Logan","year":"1990","journal-title":"Cereb Blood Flow Metab"},{"key":"10.1016\/j.nucmedbio.2011.08.003_bb0085","doi-asserted-by":"crossref","first-page":"841","DOI":"10.2967\/jnumed.108.058875","article-title":"2-18F-fluoroacetate: a useful tool for assessing gliosis in the central nervous system?","volume":"50","author":"Lopresti","year":"2009","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2011.08.003_bb0090","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1080\/00498250400028213","article-title":"Characterization of the fluoroacetate detoxication enzymes of rat liver cytosol","volume":"35","author":"Tu","year":"2005","journal-title":"Xenobiotica"},{"key":"10.1016\/j.nucmedbio.2011.08.003_bb0095","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/1098-2396(20010315)39:4<332::AID-SYN1017>3.0.CO;2-X","article-title":"[(11)C, (127)I]altropane: a highly selective ligand for PET imaging of dopamine transporter sites","volume":"39","author":"Fischman","year":"2001","journal-title":"Synapse"},{"key":"10.1016\/j.nucmedbio.2011.08.003_bb0100","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/1098-2396(200008)37:2<109::AID-SYN5>3.0.CO;2-3","article-title":"Fluorine-18-labeled tropane analogs for PET imaging studies of the dopamine transporter","volume":"37","author":"Mach","year":"2000","journal-title":"Synapse"},{"key":"10.1016\/j.nucmedbio.2011.08.003_bb0105","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1007\/s00259-003-1212-3","article-title":"[11C]PE2I: a highly selective radioligand for PET examination of the dopamine transporter in monkey and human brain","volume":"30","author":"Halldin","year":"2003","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["Nuclear Medicine and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805111001922?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805111001922?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T12:16:26Z","timestamp":1741868186000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969805111001922"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S0969805111001922"],"URL":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2011.08.003","relation":{},"ISSN":["0969-8051"],"issn-type":[{"value":"0969-8051","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]}}}